Tempest Therapeutics Statistics

Total Valuation

TPST has a market cap or net worth of $41.65 million. The enterprise value is $36.03 million.

Market Cap	41.65M
Enterprise Value	36.03M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

TPST has 4.44 million shares outstanding. The number of shares has increased by 104.87% in one year.

Current Share Class	4.44M
Shares Outstanding	4.44M
Shares Change (YoY)	+104.87%
Shares Change (QoQ)	+10.63%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	8.11%
Float	3.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.26
P/TBV Ratio	4.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.89.

Current Ratio	2.11
Quick Ratio	2.00
Debt / Equity	0.89
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-55.39

Financial Efficiency

Return on equity (ROE) is -322.57% and return on invested capital (ROIC) is -97.44%.

Return on Equity (ROE)	-322.57%
Return on Assets (ROA)	-81.34%
Return on Invested Capital (ROIC)	-97.44%
Return on Capital Employed (ROCE)	-250.08%
Revenue Per Employee	n/a
Profits Per Employee	-$1.80M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.63% in the last 52 weeks. The beta is -2.29, so TPST's price volatility has been lower than the market average.

Beta (5Y)	-2.29
52-Week Price Change	-43.63%
50-Day Moving Average	9.01
200-Day Moving Average	9.13
Relative Strength Index (RSI)	47.10
Average Volume (20 Days)	47,862

Short Selling Information

The latest short interest is 173,516, so 3.91% of the outstanding shares have been sold short.

Short Interest	173,516
Short Previous Month	181,847
Short % of Shares Out	3.91%
Short % of Float	4.46%
Short Ratio (days to cover)	2.49

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.37M
Pretax Income	-43.10M
Net Income	-43.10M
EBITDA	-43.09M
EBIT	-43.37M
Earnings Per Share (EPS)	-$13.92

Full Income Statement

Balance Sheet

The company has $14.28 million in cash and $8.66 million in debt, giving a net cash position of $5.62 million or $1.27 per share.

Cash & Cash Equivalents	14.28M
Total Debt	8.66M
Net Cash	5.62M
Net Cash Per Share	$1.27
Equity (Book Value)	9.78M
Book Value Per Share	2.20
Working Capital	7.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.80 million and capital expenditures -$18,000, giving a free cash flow of -$36.82 million.

Operating Cash Flow	-36.80M
Capital Expenditures	-18,000
Free Cash Flow	-36.82M
FCF Per Share	-$8.29

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-104.87%
Shareholder Yield	-104.87%
Earnings Yield	-103.48%
FCF Yield	-88.40%

Analyst Forecast

The average price target for TPST is $30.00, which is 219.83% higher than the current price. The consensus rating is "Hold".

Price Target	$30.00
Price Target Difference	219.83%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.51%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:13.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	1:13

Scores

Altman Z-Score	n/a
Piotroski F-Score	1